UBS Group AG - AMAG PHARMACEUTICALS INC ownership

AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 176 filers reported holding AMAG PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AMAG PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$171,000
-19.3%
18,233
-34.1%
0.00%
Q2 2020$212,000
+112.0%
27,648
+71.9%
0.00%
Q1 2020$100,000
-69.8%
16,080
-40.8%
0.00%
Q4 2019$331,000
-80.9%
27,142
-81.9%
0.00%
-100.0%
Q3 2019$1,730,000
+120.1%
149,734
+90.3%
0.00%
Q2 2019$786,000
+39200.0%
78,670
+59953.4%
0.00%
Q1 2019$2,000
-99.9%
131
-99.9%
0.00%
-100.0%
Q4 2018$1,478,000
+85.4%
97,256
+144.3%
0.00%
Q3 2018$797,000
+2177.1%
39,816
+2123.1%
0.00%
Q2 2018$35,000
-98.7%
1,791
-98.7%
0.00%
-100.0%
Q1 2018$2,708,000
+327.8%
134,390
+181.3%
0.00%
Q4 2017$633,000
+39.7%
47,779
+94.6%
0.00%
Q3 2017$453,000
-58.3%
24,551
-58.5%
0.00%
-100.0%
Q2 2017$1,087,000
+5938.9%
59,093
+7544.6%
0.00%
Q1 2017$18,000
-98.7%
773
-98.1%
0.00%
-100.0%
Q4 2016$1,431,000
+279.6%
41,099
+167.2%
0.00%
Q3 2016$377,000
-67.1%
15,382
-67.9%
0.00%
-100.0%
Q2 2016$1,146,000
+2287.5%
47,900
+2246.9%
0.00%
Q1 2016$48,000
-44.2%
2,041
-28.4%
0.00%
Q4 2015$86,000
-96.3%
2,852
-95.1%
0.00%
-100.0%
Q3 2015$2,334,000
-7.0%
58,743
+61.7%
0.00%0.0%
Q2 2015$2,509,000
+40.2%
36,323
+10.9%
0.00%
+100.0%
Q1 2015$1,790,000
+96.7%
32,755
+53.4%
0.00%0.0%
Q4 2014$910,00021,3490.00%
Other shareholders
AMAG PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
HealthInvest Partners AB 520,000$15,699,0007.39%
Palo Alto Investors LP 2,835,792$85,613,0004.76%
Opaleye Management Inc. 150,000$4,529,0001.89%
Engaged Capital LLC 61,425$1,854,0001.15%
IRONWOOD INVESTMENT MANAGEMENT LLC 91,400$2,759,0001.14%
Endurant Capital Management LP 111,180$3,357,0001.12%
AlphaOne Investment Services, LLC 86,817$2,621,0000.94%
ASHFORD CAPITAL MANAGEMENT INC 127,625$3,853,0000.91%
ARDSLEY ADVISORY PARTNERS LP 205,000$6,189,0000.81%
STELLIAM INVESTMENT MANAGEMENT, LP 685,000$20,680,0000.62%
View complete list of AMAG PHARMACEUTICALS INC shareholders